US Companies Moving the Markets, Evening edition <br>Fri, Oct 11, 2024 as of 4:00 pm ET

CLLS Message Board | Cellectis S.A.

https://ih.advfn.com/stock-market/NASDAQ/cellectis-$CLLS/stock-news/83912184/cell

Krazy19 · 2023-01-10EST05:01:59-04:00

CLLS Message Board | Cellectis S.A. https://ih.advfn.com/stock-market/NASDAQ/cellectis-$CLLS/stock-news/83912184/cell

home / stock / clls / clls message board

CLLS CLLS Quote CLLS Short CLLS News CLLS Articles CLLS Message Board

Message Board | Cellectis S.A. (NASDAQ:CLLS)

Subject	By	Source	When
https://ih.advfn.com/stock-market/NASDAQ/cellectis-$CLLS/stock-news/83912184/cell	Frankestin	investorshub	01/10/2023 5:27:59 PM
Cellectis Announces Positive Preliminary Clinical Data for UCART22	Frankestin	investorshub	12/14/2022 8:39:18 AM
will there be something interesting?	Frankestin	investorshub	11/01/2022 10:53:45 AM
also interesting here!	Frankestin	investorshub	06/01/2022 5:10:36 PM
News: $CLLS Cellectis and Lonza Enter cGMP Manufacturing	whytestocks	investorshub	10/01/2019 8:40:21 PM
J.P Morgan Healthcare conference presentation is worth listening	n4807g	investorshub	01/09/2018 1:27:54 PM
Not uncommon with new therapies. Much too	n4807g	investorshub	09/05/2017 12:54:03 PM
https://seekingalpha.com/news/3293436-cellectis-29-percent-premarket-fda-hold-st	Avispa	investorshub	09/05/2017 11:51:33 AM
FDA imposes clinical hold on CART-123.... patient death.	north40000	investorshub	09/05/2017 10:51:28 AM
with the$ GILD acquisition of$ KITE the potential	n4807g	investorshub	08/28/2017 3:58:31 PM
Cellectis$CAR-T cells act as universal donor cells.	u508	investorshub	02/10/2017 6:16:12 PM
I read that too. The CART Space is	Sixman	investorshub	02/10/2017 4:51:06 PM
interest due to successful treatment of little girl	u508	investorshub	02/09/2017 6:04:03 PM
Lots of interest last few days. Anyone out	Sixman	investorshub	02/09/2017 4:10:01 AM
Sincerely i have no idea It was 45 dollars Now	lucmariepierre	investorshub	10/14/2016 4:16:06 PM
Anyone have any idea on when the first	murocman	investorshub	07/02/2016 10:12:55 PM
CNBC : $CLLS ==> 100$ ! ???	biscotte	investorshub	05/09/2016 5:31:14 PM
http://in.reuters.com/article/us-health-celltherapy-idINKCN0XX1F7?feedType=RSS&feedName=health&a	north40000	investorshub	05/06/2016 4:19:58 PM
Post-Holiday Action: Movers and Shakers in Biotech -	venturecapp	investorshub	12/28/2015 4:56:41 PM
Et like da (I) not da (o)(o)	MrPoppaGeorgeo	investorshub	11/07/2015 1:57:10 AM

Stock Information

Get CLLS Alerts

News, Short Squeeze, Breakout and More Instantly...

Cellectis S.A. Company Name:

CLLS Stock Symbol:

NASDAQ Market:

Cellectis S.A. Website:

Cellectis S.A. Logo

CLLS - FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis' UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment

ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated 1 There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transpl...
CLLS - Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today a shareholders general meeting at 2:30 p.m. CET at the Biopark...
CLLS - Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a...